Reduced Transferrin Levels in Active Inflammatory Bowel Disease

Reduced Transferrin Levels in Active Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is an inflammatory disease of unclear etiopathogenesis and challenging diagnosis, frequently complicated by anemia and malnutrition. C-reactive protein (CRP) remains the only biochemical marker of clinical relevance. The aim of this study was to test hypothesis that...

Full description

Bibliographic Details
Main Authors:	Malgorzata Matusiewicz, Katarzyna Neubauer, Paulina Lewandowska, Andrzej Gamian, Malgorzata Krzystek-Korpacka
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/9541370

Similar Items

Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
by: Malgorzata Matusiewicz, et al.
Published: (2014-01-01)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-06-01)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-08-01)

Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results
by: Katarzyna Neubauer, et al.
Published: (2018-01-01)

Bile Acid Signaling in Inflammatory Bowel Disease
by: Mariusz A. Bromke, et al.
Published: (2021-08-01)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
by: Mariusz A. Bromke, et al.
Published: (2021-05-01)

Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment
by: Katarzyna Neubauer, et al.
Published: (2019-04-01)

Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD
by: Katarzyna Neubauer, et al.
Published: (2018-01-01)

Plasma serotonin level in left-sided colonic diverticulosis: A pilot study
by: Neubauer Katarzyna, et al.
Published: (2012-10-01)

Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-02-01)

Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
by: Katarzyna Neubauer, et al.
Published: (2015-01-01)

Distinct Chemokine Dynamics in Early Postoperative Period after Open and Robotic Colorectal Surgery
by: Malgorzata Krzystek-Korpacka, et al.
Published: (2019-06-01)

Effects of transferrin on aromatase activity in porcine granulosa cells in vitro.
by: Małgorzata Duda, et al.
Published: (2009-01-01)

Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings
by: Paulina Lewandowska, et al.
Published: (2021-12-01)

Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance
by: Dorota Diakowska, et al.
Published: (2020-10-01)

Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS)
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2019-01-01)

Antioxidant Therapy in Inflammatory Bowel Diseases
by: Katarzyna Dziąbowska-Grabias, et al.
Published: (2021-03-01)

Serum adropin levels are reduced in patients with inflammatory bowel diseases
by: Darko Brnić, et al.
Published: (2020-06-01)

Thousand words about alcohol use disorder in inflammatory bowel disease
by: Dominika Wietrzykowska, et al.
Published: (2021-03-01)

Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
by: Katarzyna Akutko, et al.
Published: (2021-06-01)

Cardiovascular Insufficiency, Abdominal Sepsis, and Patients’ Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS)
by: Iwona Bednarz-Misa, et al.
Published: (2019-01-01)

Reduced metal transferrin binding in neurological diseases
by: Hodgkins, Paul S.
Published: (1992)

Leukocytapheresis in patients with inflammatory bowel diseases
by: Małgorzata Woźniak, et al.
Published: (2021-06-01)

Inflammatory Bowel Disease Etiology: Current Knowledge
by: Kikut Justyna, et al.
Published: (2018-12-01)

Inflammatory bowel disease — is there something new in the immunological background?
by: Andrzej Marszałek, et al.
Published: (2011-07-01)

Sitagliptin Modulates Oxidative, Nitrative and Halogenative Stress and Inflammatory Response in Rat Model of Hepatic Ischemia-Reperfusion
by: Małgorzata Trocha, et al.
Published: (2021-07-01)

Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers
by: Iwona Bednarz-Misa, et al.
Published: (2019-06-01)

Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease—Systematic Review
by: Dominika Ślósarz, et al.
Published: (2021-09-01)

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease.
by: Jihye Park, et al.
Published: (2020-01-01)

Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease
by: Dawei Gong, et al.
Published: (2016-01-01)

Inflammatory bowel disease &#8212; is there something new in the immunological background?
by: Michał Drews, et al.
Published: (2011-07-01)

The value of adenosine deaminase level in assessing activation of inflammatory bowel disease
by: Züleyha Akkan Çetinkaya, et al.
Published: (2020-08-01)

Liver Disorders in Inflammatory Bowel Disease
by: Macarena Klein, et al.
Published: (2020-06-01)

Biomarkers of inflammatory bowel disease activity
by: N A Fadeeva, et al.
Published: (2018-12-01)

Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
by: Mariusz G. Fleszar, et al.
Published: (2020-11-01)

Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01)

An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease
by: Zehra Betül Paköz, et al.
Published: (2015-01-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Does the Level of Reproductive Knowledge Specific to Inflammatory Bowel Disease Predict Childlessness among Women with Inflammatory Bowel Disease?
by: Vivian W Huang, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_u7si2rb5kb7huolr3gbljqqg3d